Weak efficacy, renal risks force GSK to dump a resveratrol program - FierceBiotech PDF Print
FierceBiotech
... formulation "may only offer minimal efficacy while having a potential to indirectly exacerbate a renal complication common in this patient population.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.